News
In this interview, Technology Networks spoke with Dr. Lena Jonsson, product strategy manager at Cytiva, to explore the biological, clinical and technological frontiers shaping the next generation of ...
Growing Pipeline of ADC Candidates for Various Cancer Indications is Driving the IndustryDublin, April 25, 2025 (GLOBE NEWSWIRE) -- The An ...
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases, ...
Impedance matching is one of the perpetual confusions for new electronics students, and for good reason: the idea that increasing the impedance of a circuit can lead to more power transmission is ...
Discover groundbreaking research and presentations from leading companies at the ARVO 2025 Annual Meeting, advancing ...
Quasicrystals, exotic states of matter characterized by an ordered structure with non-repeating spatial patterns, have been the focus of numerous recent physics studies due to their unique ...
We recently published a list of 11 Oversold NASDAQ Stocks to Buy Right Now. In this article, we are going to take a look at ...
PCI Pharma Services is acquiring an entire equity stake in Ajinomoto Althea Inc. (Althea), a U.S.-based sterile fill-finish ...
Strategic investing beats market predictions. Read here for two stocks that offer reliable income, strong business models, ...
Collaborations are important in biopharma manufacturing because biologic medicines, particularly new modalities, such as ...
Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...
While simply explained here, ADCs are incredibly complex molecules which can be engineered in a multitude of ways to result in conjugates tailored to address a wide range of indications.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results